{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:32:51Z","timestamp":1794486771076,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["C19\/BM\/13535609"],"award-info":[{"award-number":["C19\/BM\/13535609"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001866","name":"Fonds National de la Recherche Luxembourg","doi-asserted-by":"publisher","award":["FNR\/NCER13\/BM\/11264123"],"award-info":[{"award-number":["FNR\/NCER13\/BM\/11264123"]}],"id":[{"id":"10.13039\/501100001866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>MIRO1 is a mitochondrial outer membrane protein important for mitochondrial distribution, dynamics and bioenergetics. Over the last decade, evidence has pointed to a link between MIRO1 and Parkinson\u2019s disease (PD) pathogenesis. Moreover, a heterozygous MIRO1 mutation (p.R272Q) was identified in a PD patient, from which an iPSC-derived midbrain organoid model was derived, showing MIRO1 mutant-dependent selective loss of dopaminergic neurons. Herein, we use patient-specific iPSC-derived midbrain organoids carrying the MIRO1 p.R272Q mutation to further explore the cellular and molecular mechanisms involved in dopaminergic neuron degeneration. Using single-cell RNA sequencing (scRNAseq) analysis and metabolic modeling we show that the MIRO1 p.R272Q mutation affects the dopaminergic neuron developmental path leading to metabolic deficits and disrupted neuron-astrocyte metabolic crosstalk, which might represent an important pathogenic mechanism leading to their loss.<\/jats:p>","DOI":"10.1038\/s41540-025-00509-x","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T10:50:48Z","timestamp":1744887048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["MIRO1 mutation leads to metabolic maladaptation resulting in Parkinson\u2019s disease-associated dopaminergic neuron loss"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3724-540X","authenticated-orcid":false,"given":"Alise","family":"Zagare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8225-2954","authenticated-orcid":false,"given":"Thomas","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyriaki","family":"Barmpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejko","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Christian","family":"Schwamborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4866-8790","authenticated-orcid":false,"given":"Claudia","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"509_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn.2017.25","volume":"18","author":"S Przedborski","year":"2017","unstructured":"Przedborski, S. The two-century journey of Parkinson disease research. Nat. Rev. Neurosci. 18, 251\u2013259 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"509_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou, Z. et al. Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson\u2019s Disease in 204 Countries\/Territories From 1990 to 2019. Front Public Health 9, 776847 (2021).","journal-title":"Front Public Health"},{"key":"509_CR3","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.3389\/fneur.2019.01284","volume":"10","author":"EL Germer","year":"2019","unstructured":"Germer, E. L. et al. The Role of Rare Coding Variants in Parkinson\u2019s Disease GWAS Loci. Front Neurol. 10, 1284 (2019).","journal-title":"Front Neurol."},{"key":"509_CR4","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1093\/brain\/awad214","volume":"146","author":"MB Makarious","year":"2023","unstructured":"Makarious, M. B. et al. Large-scale rare variant burden testing in Parkinson\u2019s disease. Brain 146, 4622\u20134632 (2023).","journal-title":"Brain"},{"key":"509_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/srep33019","volume":"6","author":"JL Klosowiak","year":"2016","unstructured":"Klosowiak, J. L. et al. Structural insights into Parkin substrate lysine targeting from minimal Miro substrates. Sci. Rep. 6, 33019 (2016).","journal-title":"Sci. Rep."},{"key":"509_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3389\/fneur.2020.00587","volume":"11","author":"D Grossmann","year":"2020","unstructured":"Grossmann, D., Berenguer-Escuder, C., Chemla, A., Arena, G. & Kruger, R. The Emerging Role of RHOT1\/Miro1 in the Pathogenesis of Parkinson\u2019s Disease. Front Neurol. 11, 587 (2020).","journal-title":"Front Neurol."},{"key":"509_CR7","doi-asserted-by":"publisher","unstructured":"Berenguer-Escuder, C. et al. Variants in Miro1 Cause Alterations of ER-Mitochondria Contact Sites in Fibroblasts from Parkinson\u2019s Disease Patients. J. Clin. Med. 8, https:\/\/doi.org\/10.3390\/jcm8122226 (2019).","DOI":"10.3390\/jcm8122226"},{"key":"509_CR8","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1089\/ars.2018.7718","volume":"31","author":"D Grossmann","year":"2019","unstructured":"Grossmann, D. et al. Mutations in RHOT1 Disrupt Endoplasmic Reticulum-Mitochondria Contact Sites Interfering with Calcium Homeostasis and Mitochondrial Dynamics in Parkinson\u2019s Disease. Antioxid. Redox Signal 31, 1213\u20131234 (2019).","journal-title":"Antioxid. Redox Signal"},{"key":"509_CR9","doi-asserted-by":"publisher","unstructured":"Chemla, A. et al. Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron loss. Brain awaf051, https:\/\/doi.org\/10.1093\/brain\/awaf051 (2025).","DOI":"10.1093\/brain\/awaf051"},{"key":"509_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.966209","volume":"15","author":"L Schwarz","year":"2022","unstructured":"Schwarz, L. et al. Miro1 R272Q disrupts mitochondrial calcium handling and neurotransmitter uptake in dopaminergic neurons. Front Mol. Neurosci. 15, 966209 (2022).","journal-title":"Front Mol. Neurosci."},{"key":"509_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.31083\/j.fbl2901036","volume":"29","author":"A Blagov","year":"2024","unstructured":"Blagov, A. et al. Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson\u2019s Disease. Front Biosci. (Landmark Ed.) 29, 36 (2024).","journal-title":"Front Biosci. (Landmark Ed.)"},{"key":"509_CR12","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1089\/scd.2017.0289","volume":"27","author":"JC Schwamborn","year":"2018","unstructured":"Schwamborn, J. C. Is Parkinson\u2019s Disease a Neurodevelopmental Disorder and Will Brain Organoids Help Us to Understand It?. Stem Cells Dev. 27, 968\u2013975 (2018).","journal-title":"Stem Cells Dev."},{"key":"509_CR13","doi-asserted-by":"publisher","unstructured":"Akrioti, E. et al. Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson\u2019s Disease. Biomolecules 12, https:\/\/doi.org\/10.3390\/biom12070876 (2022).","DOI":"10.3390\/biom12070876"},{"key":"509_CR14","doi-asserted-by":"publisher","unstructured":"Wulansari, N. et al. Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson\u2019s disease-linked DNAJC6 mutations. Sci. Adv. 7, https:\/\/doi.org\/10.1126\/sciadv.abb1540 (2021).","DOI":"10.1126\/sciadv.abb1540"},{"key":"509_CR15","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41531-023-00616-8","volume":"9","author":"I Rosety","year":"2023","unstructured":"Rosety, I. et al. Impaired neuron differentiation in GBA-associated Parkinson\u2019s disease is linked to cell cycle defects in organoids. NPJ Parkinsons Dis. 9, 166 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"509_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ajhg.2021.12.009","volume":"109","author":"A Zagare","year":"2022","unstructured":"Zagare, A. et al. Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression. Am. J. Hum. Genet 109, 311\u2013327 (2022).","journal-title":"Am. J. Hum. Genet"},{"key":"509_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s42003-023-05548-w","volume":"6","author":"A Zagare","year":"2023","unstructured":"Zagare, A. et al. Omics data integration suggests a potential idiopathic Parkinson\u2019s disease signature. Commun. Biol. 6, 1179 (2023).","journal-title":"Commun. Biol."},{"key":"509_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fnins.2020.00213","volume":"14","author":"VR Muddapu","year":"2020","unstructured":"Muddapu, V. R., Dharshini, S. A. P., Chakravarthy, V. S. & Gromiha, M. M. Neurodegenerative Diseases - Is Metabolic Deficiency the Root Cause?. Front Neurosci. 14, 213 (2020).","journal-title":"Front Neurosci."},{"key":"509_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","volume":"14","author":"A Masato","year":"2019","unstructured":"Masato, A., Plotegher, N., Boassa, D. & Bubacco, L. Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis. Mol. Neurodegener. 14, 35 (2019).","journal-title":"Mol. Neurodegener."},{"key":"509_CR20","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1038\/s41598-020-71329-8","volume":"10","author":"TM Sonninen","year":"2020","unstructured":"Sonninen, T. M. et al. Metabolic alterations in Parkinson\u2019s disease astrocytes. Sci. Rep. 10, 14474 (2020).","journal-title":"Sci. Rep."},{"key":"509_CR21","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","volume":"25","author":"C Pacelli","year":"2015","unstructured":"Pacelli, C. et al. Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons. Curr. Biol. 25, 2349\u20132360 (2015).","journal-title":"Curr. Biol."},{"key":"509_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fncom.2013.00013","volume":"7","author":"EK Pissadaki","year":"2013","unstructured":"Pissadaki, E. K. & Bolam, J. P. The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson\u2019s disease. Front Comput Neurosci. 7, 13 (2013).","journal-title":"Front Comput Neurosci."},{"key":"509_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04102-z","volume":"7","author":"A Sala","year":"2017","unstructured":"Sala, A. et al. Altered brain metabolic connectivity at multiscale level in early Parkinson\u2019s disease. Sci. Rep. 7, 4256 (2017).","journal-title":"Sci. Rep."},{"key":"509_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nbt.4072","volume":"36","author":"E Brunk","year":"2018","unstructured":"Brunk, E. et al. Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat. Biotechnol. 36, 272\u2013281 (2018).","journal-title":"Nat. Biotechnol."},{"key":"509_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/mds.28810","volume":"37","author":"J Jarazo","year":"2022","unstructured":"Jarazo, J. et al. Parkinson\u2019s Disease Phenotypes in Patient Neuronal Cultures and Brain Organoids Improved by 2-Hydroxypropyl-\u03b2-Cyclodextrin Treatment. Mov. Disord. 37, 80\u201394 (2022).","journal-title":"Mov. Disord."},{"key":"509_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41531-019-0078-4","volume":"5","author":"LM Smits","year":"2019","unstructured":"Smits, L. M. et al. Modeling Parkinson\u2019s disease in midbrain-like organoids. npj Parkinson\u2019s Dis. 5, 5 (2019).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"509_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17374-3","volume":"11","author":"AC Fahed","year":"2020","unstructured":"Fahed, A. C. et al. Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat. Commun. 11, 3635 (2020).","journal-title":"Nat. Commun."},{"key":"509_CR28","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.12998\/wjcc.v11.i15.3385","volume":"11","author":"L Gradisnik","year":"2023","unstructured":"Gradisnik, L. & Velnar, T. Astrocytes in the central nervous system and their functions in health and disease: A review. World J. Clin. Cases 11, 3385\u20133394 (2023).","journal-title":"World J. Clin. Cases"},{"key":"509_CR29","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.stemcr.2017.03.010","volume":"8","author":"AS Monzel","year":"2017","unstructured":"Monzel, A. S. et al. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells. Stem Cell Rep. 8, 1144\u20131154 (2017).","journal-title":"Stem Cell Rep."},{"key":"509_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","volume":"25","author":"T Kamath","year":"2022","unstructured":"Kamath, T. et al. Single-cell genomic profiling of human dopamine neurons identifies a population that selectively degenerates in Parkinson\u2019s disease. Nat. Neurosci. 25, 588\u2013595 (2022).","journal-title":"Nat. Neurosci."},{"key":"509_CR31","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"509_CR32","doi-asserted-by":"publisher","unstructured":"Pacheco, M. P., Ji, J., Prohaska, T., Garcia, M. M. & Sauter, T. scFASTCORMICS: A Contextualization Algorithm to Reconstruct Metabolic Multi-Cell Population Models from Single-Cell RNAseq Data. Metabolites 12, https:\/\/doi.org\/10.3390\/metabo12121211 (2022).","DOI":"10.3390\/metabo12121211"},{"key":"509_CR33","unstructured":"Clarke D. D., Sokoloff. L. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. 6th edition edn, (1999)."},{"key":"509_CR34","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1007\/s11064-012-0847-5","volume":"37","author":"C Rae","year":"2012","unstructured":"Rae, C., Fekete, A. D., Kashem, M. A., Nasrallah, F. A. & Broer, S. Metabolism, compartmentation, transport and production of acetate in the cortical brain tissue slice. Neurochem Res. 37, 2541\u20132553 (2012).","journal-title":"Neurochem Res."},{"key":"509_CR35","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.cell.2018.08.040","volume":"175","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Acetate Production from Glucose and Coupling to Mitochondrial Metabolism in Mammals. Cell 175, 502\u2013513 e513 (2018).","journal-title":"Cell"},{"key":"509_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/brx2.6","volume":"1","author":"B-L Wang","year":"2023","unstructured":"Wang, B. -L., Wu, J. -F., Xiao, D., Wu, B. & Wei, D. -X. 3-hydroxybutyrate in the brain: Biosynthesis, function, and disease therapy. Brain-X 1, e6 (2023).","journal-title":"Brain-X"},{"key":"509_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1217451","volume":"17","author":"YM Zhang","year":"2023","unstructured":"Zhang, Y. M. et al. Astrocyte metabolism and signaling pathways in the CNS. Front Neurosci. 17, 1217451 (2023).","journal-title":"Front Neurosci."},{"key":"509_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1544-y","volume":"10","author":"L Gong","year":"2019","unstructured":"Gong, L. et al. The mevalonate coordinates energy input and cell proliferation. Cell Death Dis. 10, 327 (2019).","journal-title":"Cell Death Dis."},{"key":"509_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.celrep.2016.09.004","volume":"17","author":"G L\u00f3pez-Dom\u00e9nech","year":"2016","unstructured":"L\u00f3pez-Dom\u00e9nech, G. et al. Loss of Dendritic Complexity Precedes Neurodegeneration in a Mouse Model with Disrupted Mitochondrial Distribution in Mature Dendrites. Cell Rep. 17, 317\u2013327 (2016).","journal-title":"Cell Rep."},{"key":"509_CR40","doi-asserted-by":"publisher","first-page":"E3631","DOI":"10.1073\/pnas.1402449111","volume":"111","author":"TT Nguyen","year":"2014","unstructured":"Nguyen, T. T. et al. Loss of Miro1-directed mitochondrial movement results in a novel murine model for neuron disease. Proc. Natl. Acad. Sci. USA 111, E3631\u2013E3640 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"509_CR41","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","volume":"14","author":"M Belanger","year":"2011","unstructured":"Belanger, M., Allaman, I. & Magistretti, P. J. Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metab. 14, 724\u2013738 (2011).","journal-title":"Cell Metab."},{"key":"509_CR42","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1073\/pnas.0831078100","volume":"100","author":"Y Itoh","year":"2003","unstructured":"Itoh, Y. et al. Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo. Proc. Natl. Acad. Sci. USA 100, 4879\u20134884 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"509_CR43","doi-asserted-by":"publisher","unstructured":"Bittner, C. X. et al. High resolution measurement of the glycolytic rate. Front Neuroenergetics 2, https:\/\/doi.org\/10.3389\/fnene.2010.00026 (2010).","DOI":"10.3389\/fnene.2010.00026"},{"key":"509_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105766","volume":"170","author":"RE Henn","year":"2022","unstructured":"Henn, R. E. et al. Glial-neuron crosstalk in health and disease: A focus on metabolism, obesity, and cognitive impairment. Neurobiol. Dis. 170, 105766 (2022).","journal-title":"Neurobiol. Dis."},{"key":"509_CR45","doi-asserted-by":"publisher","first-page":"E978","DOI":"10.1152\/ajpendo.1998.274.6.E978","volume":"274","author":"B Mittendorfer","year":"1998","unstructured":"Mittendorfer, B., Sidossis, L. S., Walser, E., Chinkes, D. L. & Wolfe, R. R. Regional acetate kinetics and oxidation in human volunteers. Am. J. Physiol.-Endocrinol. Metab. 274, E978\u2013E983 (1998).","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"509_CR46","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.cmet.2019.06.002","volume":"30","author":"C Jang","year":"2019","unstructured":"Jang, C. et al. Metabolite exchange between mammalian organs quantified in pigs. Cell Metab. 30, 594\u2013606.e593 (2019).","journal-title":"Cell Metab."},{"key":"509_CR47","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bbadis.2009.07.014","volume":"1802","author":"IG Onyango","year":"2010","unstructured":"Onyango, I. G. et al. Regulation of neuron mitochondrial biogenesis and relevance to brain health. Biochimica et. Biophysica Acta (BBA) - Mol. Basis Dis. 1802, 228\u2013234 (2010).","journal-title":"Biochimica et. Biophysica Acta (BBA) - Mol. Basis Dis."},{"key":"509_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.885500","volume":"14","author":"XY Gao","year":"2022","unstructured":"Gao, X. Y., Yang, T., Gu, Y. & Sun, X. H. Mitochondrial Dysfunction in Parkinson\u2019s Disease: From Mechanistic Insights to Therapy. Front Aging Neurosci. 14, 885500 (2022).","journal-title":"Front Aging Neurosci."},{"key":"509_CR49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00441-017-2768-8","volume":"373","author":"SB Larsen","year":"2018","unstructured":"Larsen, S. B., Hanss, Z. & Kruger, R. The genetic architecture of mitochondrial dysfunction in Parkinson\u2019s disease. Cell Tissue Res.373, 21\u201337 (2018).","journal-title":"Cell Tissue Res."},{"key":"509_CR50","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/mds.27609","volume":"34","author":"X Huang","year":"2019","unstructured":"Huang, X. et al. Brain cholesterol metabolism and Parkinson\u2019s disease. Mov. Disord. 34, 386\u2013395 (2019).","journal-title":"Mov. Disord."},{"key":"509_CR51","doi-asserted-by":"publisher","unstructured":"Garcia-Sanz, P., J, M. F. G. A. & Moratalla, R. The Role of Cholesterol in alpha-Synuclein and Lewy Body Pathology in GBA1 Parkinson\u2019s Disease. Mov Disord 36, 1070-1085, https:\/\/doi.org\/10.1002\/mds.28396 (2021).","DOI":"10.1002\/mds.28396"},{"key":"509_CR52","doi-asserted-by":"publisher","first-page":"554","DOI":"10.5607\/en.2019.28.5.554","volume":"28","author":"U Jin","year":"2019","unstructured":"Jin, U., Park, S. J. & Park, S. M. Cholesterol Metabolism in the Brain and Its Association with Parkinson\u2019s Disease. Exp. Neurobiol. 28, 554\u2013567 (2019).","journal-title":"Exp. Neurobiol."},{"key":"509_CR53","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/cdd.2011.105","volume":"19","author":"L Lim","year":"2012","unstructured":"Lim, L. et al. Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson\u2019s disease. Cell Death Differ. 19, 416\u2013427 (2012).","journal-title":"Cell Death Differ."},{"key":"509_CR54","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/bmmb.1993.1016","volume":"49","author":"R Musanti","year":"1993","unstructured":"Musanti, R., Parati, E., Lamperti, E. & Ghiselli, G. Decreased cholesterol biosynthesis in fibroblasts from patients with Parkinson disease. Biochem Med Metab. Biol. 49, 133\u2013142 (1993).","journal-title":"Biochem Med Metab. Biol."},{"key":"509_CR55","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.1620506114","volume":"114","author":"HA Ferris","year":"2017","unstructured":"Ferris, H. A. et al. Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc. Natl. Acad. Sci. USA 114, 1189\u20131194 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"509_CR56","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","volume":"45","author":"JM Dietschy","year":"2004","unstructured":"Dietschy, J. M. & Turley, S. D. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res. 45, 1375\u20131397 (2004).","journal-title":"J. Lipid Res."},{"key":"509_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41583-022-00641-1","volume":"24","author":"AN Brandebura","year":"2023","unstructured":"Brandebura, A. N., Paumier, A., Onur, T. S. & Allen, N. J. Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat. Rev. Neurosci. 24, 23\u201339 (2023).","journal-title":"Nat. Rev. Neurosci."},{"key":"509_CR58","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/01.wnr.0000223391.74575.c9","volume":"17","author":"DLA Van den Hove","year":"2006","unstructured":"Van den Hove, D. L. A. et al. Prenatal stress reduces S100B in the neonatal rat hippocampus. NeuroReport 17, 1077\u20131080 (2006).","journal-title":"NeuroReport"},{"key":"509_CR59","doi-asserted-by":"publisher","unstructured":"Ouadih-Moran, M. et al. Is S100B Involved in Attention-Deficit\/Hyperactivity Disorder (ADHD)? Comparisons with Controls and Changes Following a Triple Therapy Containing Methylphenidate, Melatonin and \u03c9-3 PUFAs. Nutrients 15, https:\/\/doi.org\/10.3390\/nu15030712 (2023).","DOI":"10.3390\/nu15030712"},{"key":"509_CR60","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.nbd.2015.06.010","volume":"82","author":"J Tong","year":"2015","unstructured":"Tong, J. et al. Low levels of astroglial markers in Parkinson\u2019s disease: relationship to \u03b1-synuclein accumulation. Neurobiol. Dis. 82, 243\u2013253 (2015).","journal-title":"Neurobiol. Dis."},{"key":"509_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-016-0186-6","volume":"9","author":"I Choi","year":"2016","unstructured":"Choi, I. et al. PINK1 expression increases during brain development and stem cell differentiation, and affects the development of GFAP-positive astrocytes. Mol. Brain 9, 5 (2016).","journal-title":"Mol. Brain"},{"key":"509_CR62","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41531-020-00137-8","volume":"6","author":"M Kano","year":"2020","unstructured":"Kano, M. et al. Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations. npj Parkinson\u2019s Dis. 6, 33 (2020).","journal-title":"npj Parkinson\u2019s Dis."},{"key":"509_CR63","doi-asserted-by":"publisher","first-page":"15199","DOI":"10.1523\/JNEUROSCI.2049-15.2015","volume":"35","author":"JG Jackson","year":"2015","unstructured":"Jackson, J. G. & Robinson, M. B. Reciprocal Regulation of Mitochondrial Dynamics and Calcium Signaling in Astrocyte Processes. J. Neurosci. 35, 15199\u201315213 (2015).","journal-title":"J. Neurosci."},{"key":"509_CR64","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1038\/nbt.1711","volume":"28","author":"NE Lewis","year":"2010","unstructured":"Lewis, N. E. et al. Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nat. Biotechnol. 28, 1279\u20131285 (2010).","journal-title":"Nat. Biotechnol."},{"key":"509_CR65","doi-asserted-by":"publisher","first-page":"e1006971","DOI":"10.1371\/journal.pcbi.1006971","volume":"15","author":"JC Lachance","year":"2019","unstructured":"Lachance, J. C. et al. BOFdat: Generating biomass objective functions for genome-scale metabolic models from experimental data. PLoS Comput Biol. 15, e1006971 (2019).","journal-title":"PLoS Comput Biol."},{"key":"509_CR66","doi-asserted-by":"publisher","first-page":"e59252","DOI":"10.1371\/journal.pone.0059252","volume":"8","author":"P Reinhardt","year":"2013","unstructured":"Reinhardt, P. et al. Derivation and expansion using only small molecules of human neural progenitors for neurodegenerative disease modeling. PLoS ONE8, e59252 (2013).","journal-title":"PLoS ONE"},{"key":"509_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100524","volume":"2","author":"A Zagare","year":"2021","unstructured":"Zagare, A., Gobin, M., Monzel, A. S. & Schwamborn, J. C. A robust protocol for the generation of human midbrain organoids. STAR Protoc. 2, 100524 (2021).","journal-title":"STAR Protoc."},{"key":"509_CR68","volume":"6","author":"S Bolognin","year":"2019","unstructured":"Bolognin, S. et al. 3D Cultures of Parkinson\u2019s Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing. Adv. Sci. (Weinh.) 6, 1800927 (2019).","journal-title":"Adv. Sci. (Weinh.)"},{"key":"509_CR69","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2020.05.011","volume":"75","author":"AS Monzel","year":"2020","unstructured":"Monzel, A. S. et al. Machine learning-assisted neurotoxicity prediction in human midbrain organoids. Parkinsonism Relat. Disord. 75, 105\u2013109 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"509_CR70","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart, T. et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888\u20131902.e1821 (2019).","journal-title":"Cell"},{"key":"509_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4314","author":"E Becht","year":"2018","unstructured":"Becht, E. et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/nbt.4314 (2018).","journal-title":"Nat. Biotechnol."},{"key":"509_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1089\/omi.2015.0168","volume":"20","author":"S Ben-Ari Fuchs","year":"2016","unstructured":"Ben-Ari Fuchs, S. et al. GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data. OMICS 20, 139\u2013151 (2016).","journal-title":"OMICS"},{"key":"509_CR73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-4939-7528-0_4","volume":"1716","author":"MP Pacheco","year":"2018","unstructured":"Pacheco, M. P. & Sauter, T. The FASTCORE Family: For the Fast Reconstruction of Compact Context-Specific Metabolic Networks Models. Methods Mol. Biol. 1716, 101\u2013110 (2018).","journal-title":"Methods Mol. Biol."},{"key":"509_CR74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/978-1-0716-2513-2_17","volume":"2535","author":"T Bintener","year":"2022","unstructured":"Bintener, T., Pacheco, M. P., Kishk, A., Didier, J & Sauter, T Drug Target Prediction Using Context-Specific Metabolic Models Reconstructed from rFASTCORMICS. Methods Mol. Biol. 2535, 221\u2013240 (2022).","journal-title":"Methods Mol. Biol."},{"key":"509_CR75","unstructured":"Varrette, S., Bouvry, P., Cartiaux, H. & Georgatos, F. In 2014 International Conference on High Performance Computing & Simulation (HPCS). 959\u2013967."},{"key":"509_CR76","doi-asserted-by":"publisher","first-page":"103145","DOI":"10.1016\/j.scr.2023.103145","volume":"71","author":"A Chemla","year":"2023","unstructured":"Chemla, A. et al. Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson\u2019s disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p.R450C) in the RHOT1 gene encoding Miro1. Stem Cell Res. 71, 103145 (2023).","journal-title":"Stem Cell Res."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00509-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00509-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T12:03:17Z","timestamp":1744891397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00509-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["509"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00509-x","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C.S. is a co-inventor on a patent covering the generation of the here-described midbrain organoids (WO2017060884A1). Furthermore, J.C.S. is a co-founder and shareholder of the company OrganoTherapeutics which makes use of midbrain organoid technology. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}